|8426631||Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same|
Compounds of the formula I in which the substituents have the meaning given in the description, processes for preparing these compounds, compositions comprising them and their use for controlling harmful fungi. ...
|8410302||Methoxyimino compounds and fungicide composition comprising same|
The present invention provides a methoxyimino compound, and a fungicide composition comprising same as an active ingredient. The methoxyimino compound of the present invention, which has an excellent antifungal activity against a wide spectrum of fungi even at a low...
|7696372||Process for preparing R-gossypol L-phenylalaninol dienamine|
This invention relates to a process for preparing R-gossypol L-phenylalaninol dienamine using non-chromatographic purification methods. In particular, the invention is directed to resolution of R- and S-gossypol L-phenylalaninol dienamine by crystallization. R-gossy...
|7619109||Polyisocyanide derivative having controlled helical main chain structure|
Disclosed are: a method for production of a polyisocyanide derivative having a stable helical main chain structure with a right-handed or left-handed helix or a mixture thereof from a single type of monomer by polymerizing an aromatic isocyanate having a substituent...
|7488840||Method for producing 2-chloromethylphenyl acetic acid derivatives|
The invention relates to a method for producing 2-chloromethylphenyl acetic acid derivatives of formula (I), in which X represents C1-C4 alkoxy or methylamino, by cleaving the ether bonds in compounds of formula (II), in which R represents C
|7411083||Substituted acetic acid derivatives|
The present invention relates generally to substituted acetic acid derivatives and methods of using them. ...
|7354905||Prodrugs of thrombin inhibitors|
There is provided compounds of formula I, R1O(O)C—CH2—(R)Cgl-Aze-Pab-R2I wherein R1 and R2 have meanings given in the description, which are useful as prodrugs of inhibitors of trypsin-li...
|7314938||Modulators of cellular adhesion|
The present invention provides compounds having formula (I): and pharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D, E, L and AR1
|7276572||Process for preparing aspartates|
The present invention relates to novel aspartates, their method of production and the use of these mono and polyaspartates as reactive components for polyisocyanates in two-component polyurethane coating compositions and for preparing polyurethane prepolymers. ...
|7265220||Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative|
Compound of formula (I): wherein: R1 represents aryl, heteroaryl or alkyl which is optionally substituted, or a group of formula —(CO)—CR6R7NR8R9 ...
|7262223||Amidine derivatives for treating amyloidosis|
The present invention relates to the use of amidine compounds in the treatment of amyloid-related diseases. In particular, the invention relates to a method of treating or preventing an amyloid-related disease in a subject comprising administering to the subject a t...
|7256191||Materials and methods for the treatment of depression|
The subject invention provides compounds which are easily metabolized by the metabolic drug detoxification systems. Particularly, fluvoxamine analogs which have been designed to include esters within the structure of the compounds are taught. Also provided are metho...
|7220781||Meta-benzamidine derivatives as serine protease inhibitors|
Compounds of formula I in which R1, R2, R3, each X, L, Y, Cy, Lp, D and n have the meanings as set out in the specification, and corresponding compounds in which the unsubstituted...
|7135587||Urea and urethane derivatives as integrin inhibitors|
Novel urea and urethane derivatives of general formula (I) in which R1, R2, R3, R5, R5′, X, Y, B, m, n and o are as defined in Patent Claim 1, and physiologically acceptable salts or solvates thereof are integrin inhibitors and can be employed for combating...
|7078475||Synergistic amine chain-extenders in polyurea spray elastomers|
Disclosed are derivatives of isophorone diamine exhibiting a synergistic relationship with other commonly employed chain extenders offering enhanced efficacy with regard to slowing of the polyurea elastomer cure profile, and processes employing their use. According ...
|7074923||Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof|
A process for preparing xanthine phosphodiesterase V inhibitors, and compounds utilized in said process. The process includes a five-step methodology for efficient synthesis of Compound 5 without intermediate purifications or separations, a dihalogenation step to sy...
The invention is concerned with novel N-(4-carbamimidoyl-phenyl)-glycine derivatives of the formula: wherein R1, E, X1 to X4 and G1 and G2 are as defined in ...
|7060248||Matrix metalloproteinase inhibitors|
Thus the present invention describes diagnostic agents comprising a diagnostic metal and a compound, wherein the compound comprises: 1-10 targeting moieties; a chelator; and 0-1 linking groups between the targeting moiety and chelator; wherein the targeting moiety i...
|6962905||Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug|
A kit of parts containing (a) a pharmaceutical formulation including a low molecular weight thrombin inhibitor, or a pharmaceutically acceptable derivative thereof, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, and (b) a pharmaceutica...
Compounds of formula (I) in which M, B1, B2, B3, B4, B5, B6, A1, A2, A3, A4, A5, A6, K1 and K2 have the meanings as indicated in the description, are novel effective tryptase inhibitors. ...
|6936719||Biaryl compounds as serine protease inhibitors|
Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating agents. ...
|6911501||Process for preparing aspartates|
The present invention relates to novel aspartates, their method of production and the use of these aspartates as reactive components for polyisocyanates in two-component polyurethane coating compositions and for preparing polyurethane prepolymers. The aspartates are...
|6809116||Materials and methods for the treatment of depression|
The subject invention provides compounds which are easily metabolized by the metobolic drug detoxification systems. Particularly, fluvoxamine analogs which have been designed to include esters within the structure of the compounds are taught. Also provided are metho...
|6740682||Meta-benzamidine derivatives as serine protease inhibitors|
The novel compound 3-amidinobenzoyl-D-phenylglycine-3-phenylanilide is useful as a serine protease inhibitor. ...
|6699994||Biaryl compounds as serine protease inhibitors|
Compounds of formula (I) are useful as inhibitors of trypsin like serine protease enzymes such as thrombin, factor VIIa, factor Xa, TF/FVIIa, and trypsin. These compounds could be useful to treat and/or prevent clotting disorders, and as anticoagulating a...
|6683110||Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis|
A novel class of methyl esters of substituted 4-oxo-2-butenoic acids and their derivatives are disclosed along with the surprising use property of these compounds as a bacteriostatic agents for humans or non-humans against mycobacteria. These compounds in...
|6645992||Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use|
Compounds of formula I, ##STR1## in which R1, R2, A, and B having the definitions set forth in the claims, are valuable pharmacologically active compounds, which exhibit a strong antithrombotic effect and are suitable, for example, f...
|6646151||Process for the preparation of pesticides|
The invention relates to a process for the preparation of compounds of the formula ##STR1## or, if appropriate, a tautomer thereof, in each case in the free form or in salt form, in which A, X, Y, Z, R2, R3, R4, R5
|6639094||Process for producing -aminoketone derivatives|
A process for producing -amino-dihalogenated methyl ketone derivatives by reacting an N-protected -amino acid ester with a dihalomethyl lithium is provided. This process is suitable for the production on an industrial scale and by this proce...
|6599938||Compounds having MIF antagonist activity|
There is disclosed a genus of optionally substituted Schiff base condensation products (and the carba analogs thereof) comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activ...
|6583177||Leukotriene B4 antagonist compounds and method for treatment|
Novel amidinophenol derivatives of formula (IB) ##STR1## and processes for the preparation thereof; compositions containing a compound of formula (IB) as active ingredient useful as antagonists of leukotine B4 and inhibitors of phospholipase A
|6566312||Amine reaction compounds comprising one or more active ingredient|
The present invention relates to a product of reaction between a primary and/or secondary amine and one or more active ingredients. By the present invention, there is provided a release of the active component over a longer period of time than by the use ...
|6552080||Fungicidal compounds having a fluorovinyl-or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof|
A fungicidal compound of formula (I) having a fluorovinye- or fluoropropenyl-oxyphenyloxime moiety and stereoisomers thereof are useful for protecting crops from fungal diseases: wherein, X is CH or N; Y is O or NH; R1 is hydrogen, C1-4
N-(4-carbamimidoyl-phenyl)-glycine derivatives have the formula: ##STR1## wherein X and R1 to R5 are as defined herein, and includes hydrates or solvates and/or physiologically acceptable salts thereof and/or physiologically acceptab...
|6545056||Aryl nitrone therapeutics and methods for treating inflammatory bowel disease|
Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using aryl nitrone compounds. Pharmaceutical compositions containing aryl nitrone compounds which are useful for the treatment or prophylaxis of IBD are also disclosed....
|6534283||Method for treatment and prevention of physiological shock|
Shock is a life threatening complication in situations associated with trauma including burns, surgery, ischemia, sepsis, and other critical care applications. Shock is induced by pancreatic proteases when they are released into the small intestine when t...
|6534546||Aniline derivatives possessing an inhibitory effect of nitric oxide synthase|
Compounds represented by the general formula (1): ##STR1## (where R1 is SR6 or NR7 R8, where R6 is typically an alkyl group having 1-6 carbon atoms, R7 is a hydrogen atom, an alkyl group having ...
|6509379||Phenylacetic acid derivatives, process and intermediate products for their preparation, and their use as fungicides and pesticides|
Phenylacetic acid derivatives of the formula I ##STR1## where the variables are as disclosed herein, their salts, processes and intermediates for their preparation, and their use for controlling harmful fungi and animal pests....
|6482984||Iminooxy-substituted benzyl phenyl ethers, processes and intermediates for their preparation, compositions comprising them, and their use for controlling harmful fungi|
Iminooxy-substituted benzyl phenyl ethers of the formula I ##STR1## in which the substituents and the index are as defined below: Y is H, CH3, F or Cl; Q is C(.dbd.CHOCH3)--COOCH3, C(.dbd.CHCH3)--COOCH3, C...
|6476250||Optically active fluorinated binaphthol derivative|
In order to provide a novel optically active binaphthol derivative useful as an asymmetric catalyst or the like, with which a higher reaction yield and a higher optical yield (selectivity) may be attained in asymmetric synthesis, an asymmetric catalyst us...